KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) EBIT Margin (2018 - 2025)

Historic EBIT Margin for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to 72267.92%.

  • Vir Biotechnology's EBIT Margin fell 625492600.0% to 72267.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 3253.6%, marking a year-over-year decrease of 24789300.0%. This contributed to the annual value of 791.27% for FY2024, which is 27700.0% up from last year.
  • Vir Biotechnology's EBIT Margin amounted to 72267.92% in Q3 2025, which was down 625492600.0% from 9754.28% recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's EBIT Margin registered a high of 82.26% during Q1 2022, and its lowest value of 72267.92% during Q3 2025.
  • Moreover, its 5-year median value for EBIT Margin was 828.12% (2023), whereas its average is 6583.54%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 81102500bps in 2022, then tumbled by -625492600bps in 2025.
  • Vir Biotechnology's EBIT Margin (Quarter) stood at 70.35% in 2021, then tumbled by -533bps to 304.6% in 2022, then crashed by -172bps to 828.12% in 2023, then decreased by -14bps to 946.74% in 2024, then tumbled by -7533bps to 72267.92% in 2025.
  • Its last three reported values are 72267.92% in Q3 2025, 9754.28% for Q2 2025, and 4602.47% during Q1 2025.